Strongyloides Stercoralis Test

Strongyloides stercoralis is a parasitic roundworm that lives in the small intestine and is unusual among human parasites because it can continually reinfect the same host without leaving the body. This process, called autoinfection, allows the parasite to persist for decades and often with very few symptoms. Because of this long-term survival strategy, many people carry the infection without knowing it, even though the parasite is capable of causing life-threatening illness if the immune system becomes suppressed.

The infection begins when larvae in contaminated soil penetrate the skin. After entering the bloodstream, they migrate to the lungs, move up the airway, are swallowed, and finally reach the small intestine. There, adult female worms embed in the intestinal lining and lay eggs that hatch into new larvae. Some larvae exit the body in stool, but others penetrate the intestinal wall or the skin around the anus and reenter the host’s circulation. This repeat internal cycle differentiates Strongyloides from most other intestinal worms and is the reason chronic infection is so common.

In healthy people, the infection may cause no symptoms or mild issues such as abdominal discomfort, intermittent diarrhea, nausea, or itchy skin rashes like urticaria. Blood tests often show eosinophilia, which is an increase in a type of white blood cell involved in parasite defense. However, the typical pattern can disappear in people whose immune systems are suppressed, such as those taking corticosteroids or undergoing transplantation.

When the immune system is weakened, the autoinfection cycle can accelerate dramatically. This leads to hyperinfection syndrome, where larvae multiply rapidly in the gut and lungs, and disseminated strongyloidiasis, where larvae spread throughout the body. These conditions can cause gastrointestinal bleeding, widespread bacterial infections, respiratory failure, and multi-organ damage. Because symptoms are nonspecific, the infection is often missed until severe complications develop.

Diagnosing Strongyloides is challenging because larvae are shed intermittently in stool. More sensitive tests include repeated stool examinations, concentration techniques that collect larvae more efficiently, serologic tests that identify antibodies, and molecular methods that detect parasite DNA. People who are about to start immunosuppressive medications, undergo organ transplantation, or come from areas where the parasite is common benefit from screening because undetected infection can be fatal once immunity drops.

Treatment is straightforward when caught early. Ivermectin is the preferred therapy because it interrupts larval development and halts the autoinfection cycle. Albendazole is an alternative but is generally less effective. Successful treatment often normalizes eosinophilia and resolves gastrointestinal symptoms.

Strongyloides can also influence gut microbiome composition. Studies in children and in adults with chronic kidney disease show that infection reduces beneficial bacteria and increases potentially harmful species. These changes may worsen inflammation, nutrient absorption, and overall gut function.